dc.contributor.author |
Wickramatilake, C. M. |
|
dc.contributor.author |
Mohideen, M. R. |
|
dc.contributor.author |
Pathirana, C. |
|
dc.date.accessioned |
2023-10-10T06:01:22Z |
|
dc.date.available |
2023-10-10T06:01:22Z |
|
dc.date.issued |
2016-04-11 |
|
dc.identifier.citation |
Wickramatilake, C. M., Mohideen, M. R., & Pathirana, C. (2016). High-sensitivity C-reactive protein in Sri Lankan males with coronary artery disease. Bangladesh Journal of Medical Science, 15(1), 44-50. |
en_US |
dc.identifier.issn |
2223-4721 |
|
dc.identifier.uri |
http://ir.lib.ruh.ac.lk/xmlui/handle/iruor/15020 |
|
dc.description.abstract |
Objectives: Evidence suggests that inflammation and dyslipideamia play a key role in the pathogenesis of coronary artery disease (CAD). High sensitivity C-reactive protein (hsCRP) is a sensitive marker of inflammation. We attempted to evaluate the contribution of dyslipidaemia and inflammation in CAD. Materials and methods: Three hundred and nine males (103 with myocardial infarction - MI, 103 with established CAD, 103 healthy controls) were studied. The serum hs-CRP, lipids and plasma glucose were determined. Results: Baseline mean hs-CRP levels in patients with established CAD and MI were significantly higher compared to controls (3.4 ± 1.62 VS. 1.70 ± 0.60 mg/L, p = 0.001) (3.7 ± 0.65 VS. 1.70 ± 0.60 mg/L, p = 0.001). A significant negative correlation observed between hs-CRP and HDL-Ch (r = -0.359, p = 0.001). Conclusion: Inflammation (which was reflected by elevated hs-CRP) and dyslipidamia were associated with coronary artery disease. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Ibn Sina Trust |
en_US |
dc.subject |
Coronary artery disease |
en_US |
dc.subject |
dyslipidaemia |
en_US |
dc.subject |
high- sensitivity-C-reactive protein |
en_US |
dc.title |
High-sensitivity C-reactive protein in Sri Lankan males with coronary artery disease |
en_US |
dc.type |
Article |
en_US |